Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 181-186

  Murase, Satoru ^a   Saio, Masanao ^a   Takenaka, Katsunobu ^a   Shinoda, Jun ^a   Nishimura, Yasuaki ^a   Sakai, Noboru ^a   Takami, Tsuyoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD27; Cerebrospinal fluid; Primary central nervous system lymphoma; Tumor marker

Indexed keywords

CD27 ANTIGEN; FUCHSINE; MONOCLONAL ANTIBODY; REAGENT; TETRAMETHYLBENZIDINE; TUMOR MARKER;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BRAIN TUMOR; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD27; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED;

EID: 0032561438     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00181-5     Document Type: Article

References (20)

1. Jack C.R., Reese D.F., Scheithauer B.W. Radiographic findings in 32 cases of primary CNS lymphoma. AJNR Am. J. Neuroradiol. 6:1985;899-904.
2. Kobata T., Jacquot S., Kozlowski S., Agematsu K., Schlossman S.F., Morimoto C. CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. USA. 92:1995;11249-11253.
3. Goodwin R.G., Alderson M.R., Smith C.A., Armitage R.J., VandenBos T., Jerzy R. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73:1993;447-456.
4. Kobata T., Agematsu K., Kameoka J., Schlossman S.F., Morimoto C. CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell. J. Immunol. 153:1994;5422-5432.
5. Agematsu K., Kobata T., Yang F.C., Nakazawa T., Fukushima K., Kitahara M., Mori T., Sugita K., Morimoto C., Komiyama A. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 25:1995;2825-2829.
6. Hintzen R.Q., Jong R., Hack C.E., Chamleau M., de Varies E.F., ten Berge I.J., Borst J., van Lier R.A. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147:1991;29-35.
7. van Oers M.H.J., Pals S.T., Evers L.M., van der Schoot C.E., Koopman G., Bonfrer J.M., Hintzen R.Q., von dem Borne A.E., van Lier R.A. Expression and release of CD27 in human B-cell malignancies. Blood. 82:1993;3430-3436.
8. Kersten M.J., Evers L.M., Dellemijn P.L.I., van den Berg H., Portegies P., Hintzen R.Q., van Lier R.A., von dem Borne A.E., van Oers R.H. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood. 87:1996;1985-1989.
9. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 84:1994;1361-1392.
10. Nitta T., Uda K., Ebato M., Ikezaki K., Fukui M., Sato K. Primary peripheral-postthymic T-cell lymphoma in the central nervous system: immunological and molecular approaches to diagnosis. J. Neurosurg. 82:1995;77-82.
11. O'Neil B.P., Kelly P.J., Earle J.D., Scheithauer B., Banke P.M. Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology. 37:1987;1160-1164.
12. Hochberg F.H., Miller D.C. Primary central nervous system lymphoma. J. Neurosurg. 68:1988;835-853.
13. Gabbai A.A., Hochberg F.H., Linggood R.M., Bashir R., Hotleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. J. Neurosurg. 70:1989;190-194.
14. Glass J., Gruber M.L., Cher L., Hochberg F.H. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J. Neurosurg. 81:1994;188-195.
15. Kim D.G., Nam D.H., Jung H.W., Choi K.S., Han D.H. Primary central nervous system lymphoma: variety of clinical manifestations and survival. Acta Neurochir. 138:1996;280-289.
16. Neuwelt E.A., Balaban E., Diehl J., Hill S., Frenkel E. Successful treatment of primary central nervous system lymphoma with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery. 12:1983;662-671.
17. Shibamoto Y., Tsutsui K., Dodo Y., Yamabe H., Shima N., Abe M. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicine-cyclophosphamide-prednisolone. Cancer. 65:1990;1907-1912.
18. Murray K., Kun L., Cox J. Primary malignant lymphoma of central nervous system: results of treatment of 11 cases and review of the literature. J. Neurosurg. 65:1986;600-607.
19. Bednar M.M., Salerni A., Flanagan M.E., Pendlebury W.W. Primary central nervous system T-cell lymphoma. J. Neurosurg. 74:1991;668-672.
20. Antinori A., Ammassari A., De Luca A., Cingolani A., Murri R., Scoppettuolo G., Fortini M., Tartaglione T., Larocca L.M., Zannoni G., Cattani P., Grillo R., Roselli R., Iacoangeli M., Scerrati M., Ortona L. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 48:1997;687-694.